Clinical Trial Update: Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating daunorubicin, cytarabine, and midostaurin in newly diagnosed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Midostaurin (midostaurin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 3 | Status: UNKNOWN | Results posted: 2017-02-06